Page last updated: 2024-09-03

gyki 53655 and uracil

gyki 53655 has been researched along with uracil in 1 studies

Compound Research Comparison

Studies (gyki 53655)	Trials (gyki 53655)	Recent Studies (post-2010) (gyki 53655)	Studies (uracil)	Trials (uracil)	Recent Studies (post-2010) (uracil)
111	0	22	11,300	715	2,532

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jane, DE; More, JC; Troop, HM	1

Other Studies

1 other study(ies) available for gyki 53655 and uracil

Article	Year
The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres. British journal of pharmacology, 2002, Volume: 137, Issue:7 Topics: Alanine; Animals; Animals, Newborn; Benzodiazepines; Benzyl Compounds; Dose-Response Relationship, Drug; Evoked Potentials; Excitatory Amino Acid Antagonists; Motor Neurons; Nerve Fibers; Pyrimidinones; Quinoxalines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Spinal Nerve Roots; Time Factors; Uracil	2002

Article

Year

The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres.

British journal of pharmacology, 2002, Volume: 137, Issue:7

Topics: Alanine; Animals; Animals, Newborn; Benzodiazepines; Benzyl Compounds; Dose-Response Relationship, Drug; Evoked Potentials; Excitatory Amino Acid Antagonists; Motor Neurons; Nerve Fibers; Pyrimidinones; Quinoxalines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Spinal Nerve Roots; Time Factors; Uracil

2002